Evidence map›Paper›PMID 40748324›Full record

ArticleBriefings in bioinformatics2025

PepLand: a large-scale pre-trained peptide representation model for a comprehensive landscape of both canonical and non-canonical amino acids.

Ruochi Zhang, Haoran Wu, Chang Liu, Qian Yang, Yuting Xiu, Kewei Li, Ningning Chen, Yu Wang, Yan Wang, Xin Gao and 1 more

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. PepTune:ArXiv · 2025
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ruochi ZhangKey Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University, Changchun, Jilin 130012, China.
Haoran WuSyneron Technology, Guangzhou 510700, China.
Chang LiuBeijing Life Science Academy, Beijing 102209, China.
Qian YangKey Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University, Changchun, Jilin 130012, China.
Yuting XiuSyneron Technology, Guangzhou 510700, China.
Kewei LiKey Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University, Changchun, Jilin 130012, China.
Ningning ChenSyneron Technology, Guangzhou 510700, China.
Yu WangSyneron Technology, Guangzhou 510700, China.
Yan WangKey Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University, Changchun, Jilin 130012, China.ORCID 0000-0002-4751-0708
Xin GaoComputational Bioscience Research Center, King Abdullah University of Science and Technology (KAUST) Thuwal, Thuwal 23955, Saudi Arabia.
Fengfeng ZhouKey Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University, Changchun, Jilin 130012, China.ORCID 0000-0002-8108-6007

Funding

Development Project of Jilin Province of China 20220508125RCKing Abdullah University of Science and Technology FCC/1/1976-44-01King Abdullah University of Science and Technology FCC/1/1976-45-01King Abdullah University of Science and Technology REI/1/5234-01-01King Abdullah University of Science and Technology REI/1/5289-01-01King Abdullah University of Science and Technology REI/1/5404-01-01King Abdullah University of Science and Technology REI/1/5414-01-01King Abdullah University of Science and Technology URF/1/4352-01-01
6 · The paper itself

Abstract

The recent interest in peptides incorporating non-canonical amino acids has surged within the scientific community, driven by their enhanced stability and resistance to proteolytic degradation. These so-called non-canonical peptides offer significant potential for modifying biological, pharmacological, and physiochemical characteristics in both native and synthetic contexts. Despite their advantages, there remains a notable gap in the availability of an efficient pre-trained model capable of effectively capturing feature representations from such intricate peptide sequences. This study herein introduces PepLand, a novel pre-training framework designed for the comprehensive representation and analysis of peptides, encompassing both canonical and non-canonical amino acids. PepLand leverages a general-purpose multi-view heterogeneous graph neural network to unveil the subtle structural representations of peptides. Our empirical evaluations demonstrate PepLand's proficiency in a range of peptide property prediction tasks, including cell penetrability, solubility, and protein-peptide binding affinity. These rigorous assessments affirm PepLand's superior capability in discerning critical representations of peptides with both canonical and non-canonical amino acids, and provide a robust foundation for transformative advances in peptide-focused pharmaceutical research. We have made the entire source code and datasets available at http://www.healthinformaticslab.org/supp/resources.php or https://github.com/zhangruochi/PepLand.

Indexed as

Amino AcidsComputational BiologyNeural Networks, ComputerPeptidesSoftwareAmino Acid SequenceAmino AcidsPeptidespeptide representationpeptide with non-canonical amino acidspre-trained peptide model

Identifiers

PMID40748324
PMCPMC12315545

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.